Home
Blog
Features
Sign Up
Try the Demo today!
Home
Market
Reports
Search
Alerts
Ticker
Company Name
Insider Name
Insider Trading Guide
About
Contact Us
Login
Drugs
» Biotechnology
ZIOPHARM Oncology, Inc. (TCRT)
Company Overview
Current Sentiment
Sentiment History
Insider Transactions
External Sites
Email this page »
Yahoo! Finance
CBS MarketWatch
MSN
SEC Filings
Last Year
18-Apr-23 -- 17-Apr-24
Time Period:
Three Months
|
Year
0
Net Amount
Buy:
0
--
Sell:
0
--
Company Sentiment
Biotechnology
Drugs
Sentiment Breakdown by Insider
0
(3)
0
(2)
1
(1)
35
0
0
+1
0
+2
0
+3
Two Year Chart
18-Apr-22 -- 17-Apr-24
Price ($)
Sentiment
Buy & Sell Volume ($)
Recent Insider Trades
Last Transaction
Last Three Months
SEC Filing
Transaction
Insider
Sentiment
Company
Holdings Change
Buy Amount
Sell Amount
Buy Price Range
Sell Price Range
05-Sep-23 5:34 PM
View:
01-Sep-23
Sale (Planned)
($9.54K)
Boyle Kevin S. Sr.
Chief Executive Officer
Director
ZIOPHARM Oncology, Inc. - TCRT
(8%)
866.25K to 798.24K
0
0
--
--
Show Txns
Hide Txns